Can Lab-Grown organoids predict pancreatic cancer treatment success?

NCT ID NCT06615830

First seen Feb 14, 2026 · Last updated May 15, 2026 · Updated 9 times

Summary

This study looks at whether analyzing the genes of a patient's tumor and testing drugs on lab-grown mini-tumors (organoids) can predict how well standard chemotherapy will work. About 185 adults with metastatic pancreatic cancer will provide a biopsy sample for these tests. The results are not used to choose treatment but are compared to the patient's actual response to see if the predictions are accurate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.